Dual targeting of PD-1/PD-L1 and iL-33/ST2 signalling pathways: a promising approach in breast cancer immunotherapy
Introduction The immune checkpoint axis PD-1/PD-L1 is a cornerstone of cancer immunotherapy. However, its efficacy in breast cancer is often limited by a complex and immunosuppressive tumour microenvironment (TME). The IL-33/ST2 signalling pathway, a key player in type 2 inflammation, is increasingl...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis Group
2025-12-01
|
| Serier: | Annals of Medicine |
| Fag: | |
| Online adgang: | https://www.tandfonline.com/doi/10.1080/07853890.2025.2593198 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
